BIG Data: Population Programs in Australasia and Canada AIHW analysis of bowel cancer outcomes for the NBCSP (Mon 14:05 - Meeting Room L3) click here to view session
Polyps and Adenomas - The Lumps and Bumps Challenges in Screening (Mon 16:00 - 18:00 Meeting Room L3) click here to view session
Polyps and Adenomas - The Lumps and Bumps Challenges in Screening Lesion characterization and optical diagnosis (Day 16:15 - Meeting Room L3) click here to view session
Polypectomy Update Prevention & treatment of complications of resection (Mon 15:00 - Hall M) click here to view session
Liver: Personalising HCC Management Title of given presentation (Mon 08:00 - 10:00 Riverbank Room 6) click here to view session
Liver: Free Papers: Clinical Cancer-related inflammation as a stratifying biomarker of survival in Sorafenib-treated HCC (Wed 17:45- Meeting Room L1) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 1): Personalising Screening Can genetic risk profiling aid risk categorization – the epidemiology (Tue 10:30 - Meeting Room L3) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 2): Test Options for Population and Personalised Screening Incorporation of absolute risk in to the NHMRC guidelines on colorectal cancer screening (Tue 13:30 - Meeting Room L3) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 2): Test Options for Population and Personalised Screening Panel discussion: screening technologies – their pros and cons. Colonoscopy, flexible sigmoidoscopy, molecular tests including stool DNA tests (Tue 15:00 - Meeting Room L3) click here to view session
Gastrointestinal Cancer: Free Papers and Next Steps Significantly higher prevalence of CRC in the left colon since the introduction of the NBCSP (Tue 16:24 - Meeting Room L3) click here to view session
Gastrointestinal Cancer: Free Papers and Next Steps 1 in 11 colorectal cancers found in adults younger than the age of screening (Tue 16:36 - Meeting Room L3) click here to view session
Delivery of Colonoscopy in a Screening Program What type of access does the consumer want? (Tue 08:00 - Meeting Room L1) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 1): Personalising Screening Panel discussion: Too young or too old for screening? The interface between population and personalized screening (Tue 11:45 - Meeting Room L3) click here to view session
Endoscopy: AGEA Free Papers: Lower GI Using adenoma detection quotient as a quality indicator in colonoscopy: A multicentre audit (Wed 14:30 - Riverbank Room 8) click here to view session
Basic Digestive Research Session: GI Stem Cells (Wed 10:30 - 12:30 Meeting Room L3) click here to view session GI Oncology Morphogen Gradients in the Normal and Neoplastic Colon (Wed 15:00 Riverbank Room 7) click here to view session
Polyps and Adenomas - The Lumps and Bumps Challenges in Screening Serrated lesions – what they mean for practice (Mon 16:30 - Meeting Room L3) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 1): Personalising Screening (Tue 10:30 - 12.30 Meeting Room L3) click here to view session
What are Your Treatment Targets in 2016? How to define and report endoscopic disease (Mon 08:20 - Riverbank Room 7) click here to view session
IBD: Update on Managing Disease and Treatment Risk in IBD Full Spectrum Endoscopy (FUSE) in the detection of inflammatory bowel disease neoplasia (FUSION) (Tue 11:50 - Riverbank Room 7) click here to view session
IBD: How Cost-Effective is our IBD Therapy? (Wed 13:30 - 15:30 Riverbank Room 6) click here to view session
What are Your Treatment Targets in 2016? Treat-to-target approach via a virtual clinic amongst IBD patients with secondary loss of response (Mon 09:33 - Riverbank Room 7) click here to view session
Liver Free Papers: Viral Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV Genotype 1 cirrhotic patients (Tue 10:30 - Riverbank Room 6) click here to view session
Liver: EBM Clinical Grand Round Should we bother examining our patients? (Wed 13:30 - Hall M) click here to view session
Polyps and Adenomas - The Lumps and Bumps Challenges in Screening (Mon 16:00 - 18:00 Meeting Room L3) click here to view session
Colorectal Cancer Screening Symposium — Q&A Session Can We Eradicate Colorectal Cancer. A Conversation with Experts and Consumers (Mon 18:30 -19:30 Meeting Room L3) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 2): Test Options for Population and Personalised Screening Panel discussion: screening technologies – their pros and cons. Colonoscopy, flexible sigmoidoscopy, molecular tests including stool DNA tests (Tue 15:00 - 15:30 Meeting Room L3) click here to view session
Colonoscopy: Training and Quality Training at the coalface – surgical perspective (Tue 16:20 - Riverbank Room 7) click here to view session
Young Investigator Awards (YIA) Emu Oil Attenuates Disease Severity in Models of Colitis and Colitis-Associated Colorectal Cancer (Tue 08:22 - Hall M) click here to view session
GENCA: Paediatric Emu oil promotes intestinal repair in pre-clinical models of enteric inflammation (Wed 17:35 - Meeting Room L2) click here to view session
Liver: HCV: Can DAA’s be Difficult? Difficult to treat populations: Decompensated cirrhosis and Liver Transplant (Mon 13:30 - Riverbank Room 6) click here to view session
Participation in Screening: A Crucial Element for Success Health thinking style predicts FOBT screening (Mon 17:05 - Meeting Room L1) click here to view session
Basic Digestive Research Session: GI Stem Cells Stomach: The Origin of the Normal and Neoplastic Stomach (Wed 11:10 - Meeting Room L3) click here to view session
Young Investigator Awards (YIA) Distinguishing between liquid and gas bolus movements in the colon using impedance manometry (Tue 08:11 - Hall M) click here to view session
IBD: Update on Managing Disease and Treatment Risk in IBD (Tue 10:30 - 12:30 Riverbank Room 7) click here to view session
IBD: How Cost-Effective is our IBD Therapy? Crohn’s and Colitis Australia Audit prelim results (Wed 13:30 - Riverbank Room 6) click here to view session
IBD: How Cost-Effective is our IBD Therapy? How to measure IBD costs and where we could improve (Wed 13:50 - Riverbank Room 6) click here to view session
B: What to do with the indeterminate biliary stricture? Spyglass DC: a new advance in the treatment of pancreatico-biliary disorders (Tue 11:20 - Hall M) click here to view session
GENCA: Gas Latest Developments in Endoscopy in the Upper GI Track (Tue 14:00 - Meeting Room L2) click here to view session
Innovative Developments in Colorectal Cancer Screening (Part 1): Personalising Screening Can genetic risk profiling aid risk categorization – the health economics (Tue 10:50 - Meeting Room L3) click here to view session
IBD State of the Art: The Microbiome and IBD Faecal Microbiota Transplantation in Ulcerative Colitis - Luminal & Mucosal 16S Microbiota Analysis (Wed 08:00 - Riverbank room 6) click here to view session
IBD Free Papers: Basic Australian faecal microbiota transplant trial results (Tue 14:40 - Hall M) click here to view session
BIG Data: Population Programs in Australasia and Canada Screening in New Zealand – Lessons from the NZ screening pilot Mon 15:05 - Meeting Room L3) click here to view session
Delivery of Colonoscopy in a Screening Program (Tue 08:00 - 10:00 Meeting Room L1) click here to view session
Delivery of Colonoscopy in a Screening Program All in good time: fast-tracking positive cases and other solutions to the waiting list issues (Tue 08:10 - Meeting Room L1) click here to view session
Delivery of Colonoscopy in a Screening Program All in good time: the potential role for nurse colonoscopists (Tue 08:40 - Meeting Room L1) click here to view session
BIG Data: Population Programs in Australasia and Canada Screening in Canada – How we Evaluate the Impact of Colorectal Cancer Screening (Mon 14:40 - Meeting Room L3) click here to view session
Liver Innovations and Advances In Cirrhosis Microbiome manipulation and complications of cirrhosis (Tue 13:30 - Riverbank Room 6) click here to view session
Young Investigator Awards (YIA) The application of normothermic machine perfusion to bench-test human donor livers (Tue 08:00 - Hall M) click here to view session
BIG Data: Population Programs in Australasia and Canada Can we use the population-based data we have to monitor the whole screening pathway? (Mon 13:50 - Meeting Room L3) click here to view session